Come up with a name for your new list and we'll add to it:
ACT Biotech was acquired by
Eddingpharm on January 09, 2014.
ACT Biotech aims to bring therapies to bear in managing cancer, especially in underserved disease sectors where patient need is acute. Per the company, ACT has launched an aggressive, focused developm…